Endogenous estrogens and breast cancer risk: the case for prospective cohort studies.
It is generally agreed that estrogens, and possibly androgens, are important in the etiology of breast cancer, but no consensus exists as to the precise estrogenic or androgenic environment that characterizes risk, or the exogenous factors that influence the hormonal milieu. Nearly all the epidemiological studies conducted in the 1970s and 1980s were hospital-based case-control studies in which specimen sampling was performed well after the clinical appearance of the disease. Early prospective cohort studies also had limitations in their small sample sizes or short follow-up periods. However, more recent case-control studies nested within large cohorts, such as the New York University Women's Health Study and the Ormoni e Dieta nell'Eziologia dei Tumori study in Italy, are generating new data indicating that increased levels of estrone, estradiol and bioavailable estradiol, as well as their androgenic precursors, may be associated with a 4- to 6-fold increase in the risk of postmenopausal breast cancer. Further new evidence, which complements and expands the observations from the latter studies, shows that women with the thickest bone density, which may be a surrogate for cumulated exposure to hormones, experience severalfold increased risk of subsequent breast cancer as compared to women with thin bones. These data suggests that endogenous sex hormones are a key factor in the etiology of postmenopausal breast cancer. New prospective cohort studies should be conducted to examine the role of endogenous sex hormones in blood and urine samples obtained early in the natural history of breast cancer jointly with an assessment of bone density and of other important risk factors, such as mammographic density, physical activity, body weight, and markers of individual susceptibility, which may confer increased risk through an effect on the metabolism of endogenous hormones or through specific metabolic responses to Western lifestyle and diet.
Toniolo
P G
PG
Nelson Institute of Environmental Medicine and Kaplan Cancer Center, New York University School of Medicine, New York 10010-2598, USA. paolo.toniolo@ccmail.med.nyu.edu
D001943:Breast Neoplasms / Q000209:etiology*; D016022:Case-Control Studies; D015331:Cohort Studies; D004967:Estrogens / Q000502:physiology*; D005260:Female; D006801:Humans; D009376:Neoplasms, Hormone-Dependent / Q000209:etiology*; D011446:Prospective Studies; D012107:Research Design; D012307:Risk Factors
D004967:Estrogens